
Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review
Description
Takeda Pharmaceutical Co Ltd (4502) - Financial and Strategic SWOT Analysis Review
Table of Contents
94 Pages
- Section 1 - About the Company
- Takeda Pharmaceutical Co Ltd - Key Facts
- Takeda Pharmaceutical Co Ltd - Key Employees
- Takeda Pharmaceutical Co Ltd - Key Employee Biographies
- Takeda Pharmaceutical Co Ltd - Major Products and Services
- Takeda Pharmaceutical Co Ltd - History
- Takeda Pharmaceutical Co Ltd - Company Statement
- Takeda Pharmaceutical Co Ltd - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Joint Venture
- Section 2 – Company Analysis
- Company Overview
- Takeda Pharmaceutical Co Ltd - Business Description
- Product Category: Gastroenterology
- Overview
- Performance
- Product Category: Neuroscience
- Overview
- Performance
- Product Category: Oncology
- Overview
- Performance
- Product Category: Other
- Performance
- Product Category: PDT Immunology
- Overview
- Performance
- Product Category: Rare Genetics and Other
- Performance
- Product Category: Rare Hematology
- Overview
- Performance
- Geographical Segment: Asia (excluding Japan)
- Performance
- Geographical Segment: Europe and Canada
- Performance
- Geographical Segment: Japan
- Performance
- Geographical Segment: Latin America
- Performance
- Geographical Segment: Other
- Performance
- Geographical Segment: Russia/CIS
- Performance
- Geographical Segment: U.S
- Performance
- R&D Overview
- Takeda Pharmaceutical Co Ltd - Corporate Strategy
- Takeda Pharmaceutical Co Ltd - SWOT Analysis
- SWOT Analysis - Overview
- Takeda Pharmaceutical Co Ltd - Strengths
- Takeda Pharmaceutical Co Ltd - Weaknesses
- Takeda Pharmaceutical Co Ltd - Opportunities
- Takeda Pharmaceutical Co Ltd - Threats
- Takeda Pharmaceutical Co Ltd - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 30, 2024: Takeda Reports H1 FY2024 Results
- Oct 18, 2024: Targeted Therapy, Driven by Comprehensive Genomic Profiling and Molecular Tumour Board, Improves Outcomes In Pretreated Patients with Metastatic Cancer
- Sep 18, 2024: Takeda Commits Over $32 Million in Five New Global Corporate Social Responsibility Partnerships To Further Drive Health Impact in 93 Countries
- Aug 15, 2024: Nanoform Joins Forces With Takeda on Plasma-Derived Therapy Development
- Jul 31, 2024: Takeda Announces First Quarter FY2024 Results – Strong Performance by Growth & Launch Products; Advancements in Promising Late-Stage Pipeline
- Jul 17, 2024: nference Establishes AI Initiative with Takeda to Advance Precision Medicine in Inflammatory Bowel Disease
- Jul 16, 2024: PET-2-Guided BrECADD Better Tolerated and More Effective than eBEACOPP in Patients with Newly Diagnosed, Advanced-Stage cHL
- Jun 26, 2024: Takeda Announces New Assignments of Directors
- May 21, 2024: Inspire and Takeda Researchers to Present Novel Study on Short Bowel Syndrome Patient Experience at DDW2024
- May 14, 2024: Takeda to Present Oncology Portfolio and Pipeline Data at the 2024 ASCO Annual Meeting
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- Takeda Pharmaceutical Co Ltd, Key Facts
- Takeda Pharmaceutical Co Ltd, Key Employees
- Takeda Pharmaceutical Co Ltd, Key Employee Biographies
- Takeda Pharmaceutical Co Ltd, Major Products and Services
- Takeda Pharmaceutical Co Ltd, History
- Takeda Pharmaceutical Co Ltd, Other Locations
- Takeda Pharmaceutical Co Ltd, Subsidiaries
- Takeda Pharmaceutical Co Ltd, Joint Venture
- Takeda Pharmaceutical Co Ltd, Key Competitors
- Takeda Pharmaceutical Co Ltd, Ratios based on current share price
- Takeda Pharmaceutical Co Ltd, Annual Ratios
- Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...1)
- Takeda Pharmaceutical Co Ltd, Annual Ratios (Cont...2)
- Takeda Pharmaceutical Co Ltd, Interim Ratios
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Type, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- Takeda Pharmaceutical Co Ltd, Performance Chart (2020 - 2024)
- Takeda Pharmaceutical Co Ltd, Ratio Charts
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2018 to YTD 2024
- Takeda Pharmaceutical Co Ltd, Pharmaceuticals & Healthcare, Deals by Type, 2018 to YTD 2024
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.